Found 6 matching trials
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
PHASE2The proposed project tests the efficacy of glutamate modulators in non-depr...
Facilitating Rapid Naltrexone Initiation
PHASE3The incidence of opioid use disorders (OUDs) has increased to near-epidemic...
Status
Active Not Recruiting
Location
New York State Psychiatric Institute
Glutamatergic Modulation of Disordered Alcohol Use
PHASE2Alcohol use disorders remain a significant public health problem. The pharm...
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
PHASE3Changes in the communication of glutamate from one brain structure to anoth...
The Effect of Glutamatergic Modulation on Cocaine Self-administration
PHASE2Repeated drug consumption may progress to problematic use by triggering neu...
Location
Multiple Locations
Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial
PHASE2Post-acute sequelae of SARS-CoV2 (PASC), colloquially known as "long-COVID,...
Status
Active Not Recruiting
Location
New York State Psychiatric Institute